demonstrated that LMNTD2-AS1 knockdown significantly suppressed migration, invasion, and proliferation of prostate cancer cells, effects that were reversed by FUS overexpression, suggesting that LMNTD2-AS1 may regulate immune cell infiltration and cancer progression through FUS-mediated NRF2 signaling interactions (37). Here, FUS is linked to prostate carcinoma.